Loss of Smell May Signal Early Cognitive Decline in Parkinson’s Disease, New Research Suggests
A diminished sense of smell could be an early warning sign of cognitive impairment in individuals with Parkinson’s disease, according to a new study highlighting the importance of early diagnosis and consistent management of the neurodegenerative condition.
As global populations age, the prevalence of Parkinson’s disease is rapidly increasing, prompting a renewed focus on identifying subtle indicators of the illness. Researchers are now emphasizing that a change in olfactory function—the ability to smell—may be more than a simple decrease in sensory perception.
To raise awareness, the National Institute of Health and the Korea Disease Control and Prevention Agency recently released educational materials, including “card news” detailing key aspects of Parkinson’s disease, and shared findings from a long-term cohort study on September 9th.
Parkinson’s disease is a chronic condition characterized by the progressive loss of dopamine-producing neurons in the brain. This neuronal loss leads to hallmark motor symptoms like tremors, rigidity, and gait disturbances. However, the disease also manifests in a range of non-motor symptoms, including reduced sense of smell, sleep disorders, autonomic nervous system dysfunction, and—critically—cognitive decline, all of which significantly impact quality of life.
Data from the Health Insurance Review and Assessment Service indicates a substantial rise in Parkinson’s disease cases in South Korea. The number of patients increased by approximately 13.9%, rising from 125,927 in 2020 to 143,441 in 2024. Experts predict this trend will continue as the population ages.
Long-Term Study Reveals Olfactory Link to Cognitive Function
Since 2021, the National Institute of Health has been conducting an in-depth cohort study of Parkinson’s disease patients as part of the ‘Brain Disease Research Base Creation Research Project.’ The goal is to develop improved diagnostic tools, preventative strategies, and personalized management plans for the disease.
A research team led by Professor Joong-seok Kim at Seoul St. Mary’s Hospital of the Catholic University of Korea followed 203 patients in the early stages of Parkinson’s disease for approximately five years. The team discovered a notable correlation: patients with impaired odor discrimination ability experienced a more rapid decline in cognitive function. Interestingly, the rate of motor function decline was not significantly linked to changes in smell.
“The pattern of changes in olfactory function can be a key indicator for predicting the rate of cognitive decline in Parkinson’s disease patients,” the research team explained. They further noted that a simple, non-invasive olfactory test could potentially predict the risk of cognitive decline early on, aiding in the development of more effective diagnosis and treatment strategies.
The findings, published in the September 2024 issue of the Journal of Neurology, underscore the importance of considering olfactory function as a potential biomarker for cognitive decline in Parkinson’s disease. This research offers a promising avenue for early intervention and improved patient care.